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Background: Bacterial colonisation of the respiratory tract is commonly described and usually thought to be of no
clinical significance. The aim of this study was to examine the presence and significance of bacteria and viruses in the
upper respiratory tract of healthcare workers (HCWs), and association with respiratory symptoms.
Methods: A prospective cohort study was conducted in China and 223 HCWs were recruited from fever clinics
and respiratory, paediatric, emergency/Intensive medication wards. Participants were followed over 4 weeks (7th May
2015 to 4th June 2015) for development of clinical respiratory illness (CRI). Nasopharyngeal swabs were obtained at
baseline and at the end of the study. The primary endpoints were laboratory-confirmed bacterial colonisation and viral
respiratory infection. Rates of the following infections in symptomatic and asymptomatic participants were compared
at the start or end of the study; 1) all bacterial/viral infections, 2) bacterial infection and bacterial-viral co-infections,
excluding virus only infections, and 3) only bacterial infections.
Results: Bacterial colonisation was identified in 88% (196/223) of participants at the start or end of the study. Among
these participants, 66% (148/223) had only bacterial colonisation while 22% (48/223) had co-infection with a virus.
Bacteria were isolated from 170 (76.2%) participants at baseline and 127 (57%) participants at the end of the
study. Laboratory confirmed viral infections were identified in 53 (23.8%) participants - 35 (15.7%) at the baseline
and 20 (9.0%) at the end of the study.
CRI symptoms were recorded in 12 participants (4.5%) and all had a positive bacterium isolation at baseline
(n = 11) or end of the study (n = 1). Among asymptomatic participants, 187 (87%) had bacterial colonisation or
bacterial/viral co-infection at baseline or end of the study. Viruses were also isolated from 5 (2.4%) asymptomatic
cases. Rates of all infection outcomes were higher in symptomatic participants, however differences were not
statistically significant.
Conclusion: We isolated high rates of bacteria and viruses in the upper respiratory tract of hospital HCWs, which
may reflect greater exposure to respiratory infections in the hospital. Although respiratory infections are mostly
symptomatic, the association between bacterial colonization and symptomatic illness is not clear. In the healthcare
setting, HCWs may acquire and transmit infection to patients and other HCWs around them. Larger studies are
required to explore ongoing occupational risk of respiratory infection in hospitals HCWs.
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The significance of finding pathogenic bacteria in the
upper respiratory tract is unknown, as it is generally
thought that many people are asymptomatic carriers of
colonising bacteria [1–3]. To date, there has been very
little research looking at the role of upper respiratory
tract bacteria as a cause of mild respiratory illness. Health-
care workers (HCWs) are at high risk of nosocomial infec-
tion with respiratory, blood borne and other infections
[4–6]. Respiratory infections are the leading cause of acute
infections in humans. Whilst the burden of disease is well
recognised in the elderly and immunocompromised,
limited information exists on the impact of respiratory
infections on HCWs [6–8]. Nosocomial infections among
HCWs result in increased rates of illness, absenteeism and
even death amongst HCWs [5, 9] and also comes at a
large financial cost to the health care system [10]. HCWs
may also be a source of infection in nosocomial outbreaks
[11]. Transmission of influenza from patient-to-HCW
and HCW-to-patient have been identified in many cases
highlighting the importance HCWs play in hospital trans-
mission [12].
Varying degrees of nasopharyngeal (NP) bacterial colon-
isation are reported in healthy individuals, depending on
the age of participants, site of specimen collection and
vaccination status [13, 14]. Certain factors increase the
risk of nasopharyngeal carriage such as age, geographical
area, vaccination status, immunity and socio-economic
status [1, 13–15]. There are limited data from HCWs, and
most studies are conducted in children, who generally
have higher rates of NP colonisation compared to adults
[3, 16]. Commonly isolated organisms are Streptococcus
pneumoniae (pneumococcus), Haemophilus influenzae,
Moraxella catarrhalis and Staphylococcus aureus [17].
Testing of healthy children showed 50% NP carriage rate
for S. aureus [13], 55–69% for Streptococcus pneumoniae
[13, 14, 18], 67–74%for Moraxella. catarrhalis [13, 14]
and 57–83% for Haemophilus influenzae [13, 14, 18].
In a study of both inpatients and outpatient children
the overall swab positivity rates were 31.5% (63/200),
with Streptococcus pneumoniae, Haemophilus influenzae
and Group A Streptococcus accounting for 22%, 5% and
4.5% respectively [19]. In a study in Italy, the rate of
Streptococcus pneumoniae, Haemophilus influenzae, and
Moraxella catarrhalis found 3.5%, 11.9% and 4.1%
carriage respectively (overall 17.9%) [20]. In Australian
Aboriginal adults, rates of bacterial colonisation were
26%, 23% and 17% for Streptococcus pneumoniae,
Haemophilus influenza and Moraxella catarrhalis
respectively [14]. Lower carriage rates of Haemophilus
influenzae (0%) and Streptococcus pneumoniae (10.8%)
were observed in a study in China [18]. An Australian
study also reported very low rate (1/315) of Streptococcus
pneumoniae in hospitalised elderly patients [21].The finding of a virus in the upper respiratory tract is
generally thought to be clinically significant. However
the significance of asymptomatic viral infection has not
been explored in existing literature, and viruses detected
in the upper respiratory tract are generally assumed to
be pathogenic. Some studies have found that up to 1 in
3 subjects with influenza infection may be asymptomatic
[22], whilst asymptomatic infection with parainfluenza
virus has also been observed [23]. One study also dem-
onstrated shedding of parainfluenza virus from healthy
subjects over an extended period of time [24]. Whilst
little research exists on asymptomatic viral infections,
these cases suggest that viruses can be transmitted by
asymptomatic subjects unknowingly. A better under-
standing of the role of bacterial and viral infections in
HCWs and their association with the respiratory symp-
toms is warranted. The aim of this study was to examine
the presence and significance of bacteria and viruses in
the upper respiratory tract of HCWs.
Methods
A prospective cohort study was conducted in four hospitals
in Beijing, China. Participants were hospital HCWs aged
between 18 and 65 from respiratory wards, paediatric
wards, intensive care unit, outpatient fever clinics (special
clinics in Chinese hospitals for management of febrile pa-
tients) and emergency units. Participants were followed
over a 4 week period and were asked to report any symp-
toms that developed over the study period. Recruitment
formally commenced on the 7th of May 2015 and final
follow up was completed on the 4th of June 2015.
Eligibility
HCWs (doctors and nurses) from the selected wards of
four hospitals were invited to participate in the study.
Full-time HCWs, aged 18 and over were eligible for par-
ticipation in the study. Participants were excluded if
they: [1] were unable or refused to consent; [2] had a
current respiratory illness; rhinitis and/or allergy; [3]
work part-time or [4] were not available for the 4 weeks
follow-up.
Recruitment
Information about the study was provided to staff members
by district level staff members from the Beijing Centre for
Disease Prevention and Control (CDPC). Hospital staffs
were invited to attend information sessions, which were
held at different times of the day. Information sheets and
consent forms were given out during these sessions and
interested staff members asked to return the completed
forms if they had agreed to give consent and participate in
the study. Additional copies of the participant information
sheet were also left with designated staff members from
Raina MacIntyre et al. BMC Infectious Diseases  (2017) 17:553 Page 3 of 9each ward to pass onto staff members who were unable to
attend the information sessions.
Data collection and follow up
At time of recruitment, baseline nasopharyngeal swabs
were collected by trained staff and tested in the Beijing
CDPC laboratory. Detailed demographic and clinical de-
tails for all participants were also collected. This included
age, sex, smoking history, comorbidities, vaccination
status, medications, use of personal protective equipment,
performing high risk procedures, antivirals and results of
laboratory tests.
At the end of the 4 weeks, another set of nasopharyngeal
swabs was collected from all participants. A second (exit)
survey was administered at the same time to participants to
collect information about the development of any respira-
tory symptoms in the previous 4 weeks. Clinical respiratory
illness (CRI) was defined as two or more respiratory symp-
toms (cough, nasal congestion, runny nose, sore throat or
sneezes) or one respiratory symptom and a systemic symp-
tom (chill, lethargy, loss of appetite, abdominal pain, muscle
or joint aches).
The primary endpoints were:
(1) Laboratory-confirmed bacterial colonisation in
symptomatic/non-symptomatic subjects. Multiplex
PCR was used to test for Streptococcus pneumoniae,
Legionella, Bordetella pertussis, chlamydia pneumoniae,
Mycoplasma pneumoniae or Haemophilus influenzae
type B (Seegen, Inc., Seoul, Korea).
(2) Laboratory-confirmed viral respiratory infection in
symptomatic/non-symptomatic subjects, defined as
detection of Adenoviruses, Human metapneumovirus,
Coronaviruses 229E/NL63 and OC43/HKU1,
Parainfluenzaviruses 1, 2 and 3, Influenza viruses A
and B, Respiratory syncytial viruses A and B, or
Rhinoviruses A/B by nucleic acid testing (NAT) using
a commercial multiplex polymerase chain reaction
(PCR) (Seegen, Inc., Seoul, Korea) [25].
Specimen collection and testing
Double rayon-tipped, plastic-shafted swabs were used to
scratch both tonsilar areas and the posterior pharyngeal
wall of participants. These samples were then trans-
ported immediately after collection to the Beijing CDPC
laboratories, or stored at 4 °C for up to 48 h if transport
is delayed. Viral DNA/RNA was extracted from each
respiratory specimen using the Viral Gene-spinTM Kit
(iNtRON Biotechnology, Inc., Seoul, Korea) according to
the manufacturer’s instructions. Reverse transcription
was performed using the RevertAidTM First Strand cDNA
Synthesis Kit (Fermentas, ON, Canada) to synthesise
cDNA. Multiplex PCR was carried out using the Seeplex®
RV12 Detection Kit (Seegen, Inc., Seoul, Korea). A mixtureof clones of the 12 viruses tested was used as a positive
control template, and sterile deionised water was used as a
negative control. Viral isolation by MDCK cell culture was
undertaken for some of the influenza samples that are
influenza NAT positive. NAT using a multiplex PCR was
also done on the same DNA/RNA extract as used for the
viral PCR (Seegen, Inc., Seoul, Korea). Specimen process-
ing, DNA/RNA extraction, PCR amplification, and PCR
product analyses were conducted in different rooms to
avoid cross-contamination.
Analysis
Rates of bacterial, viral and co-infections were measured
at the start and end of the study period and were also
compared in symptomatic and non-symptomatic partici-
pants. We performed analysis considering three out-
comes. First we compared rates of all bacterial infection
at the start or end of the study including bacterial/viral
co-infections, in symptomatic and asymptomatic partici-
pants. Then we compared rates of bacterial infection
and co-infection in symptomatic and asymptomatic
participants - five cases with viral only infections were
excluded from this analysis. Finally we compared rates
of only bacterial infection excluding viral co-infection, in
symptomatic and asymptomatic participants.
The primary endpoints of interest were analysed by
binary logistic regression models. Univariate analyses were
performed for main exposure variable and other variables
such as age, sex, occupation, vaccination status, perform-
ing high-risk procedures, mask use, smoking status, pre-
existing illness, respiratory symptoms within the family
and ward type. Multivariate analyses were also performed
and all variable were included in the model. The data were
analysed using SAS v. 9.4 (SAS Institute Inc., USA).
Sample size
Sample size was based on 95% confidence and 80% power
to detect difference between rates of bacterial colonisation
in symptomatic and asymptomatic individuals, if we as-
sume 20% of HCWs will have bacterial colonization.
These estimates are based on previous studies that describe
adult colonisation rates. The sample size was calculated in
Epi Info 2000 [26]. In order to allow for loss to follow up,
220 hospital staff members were to be recruited.
Ethics approval
The study protocol was approved by the Human Research
Ethics Committee of the Beijing Ministry for Health and
HREC University of New South Wales (HC14325).
Results
A total of 223 participants were recruited from four
hospitals and followed for 4 weeks. Most participants
were female (84.3%), with a graduate degree (71.3%) and
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study season (Table 1). The mean age of participants
was 36.7 years (SD ±9.7 and range 20–65 years) and
around half of them were doctors. Thirteen percent
(29/223) of participants had at least one pre-existing
medical condition and 64% (143/223) had performed
high risk procedures during the study period.
Bacteria were isolated from 170 (76.2%) participants at
baseline and 127 (57%) participants at the end of theTable 1 Demographic characteristics of participants (n = 223)
Variable Number Precent/mean SD
Gender
Male 35 15.7
Female 188 84.3
Age 36.7 (± 9.7 SD)
Profession
Doctor 104 46.6
Nurses 119 53.4
Education
Undergraduate 37 16.6
Graduate 159 71.3
Post graduate 27 12.1
Smoking status
Current/ex-smoker 11 4.9
Never 212 95.1
Influenza vaccine
Yes 48 21.5
No 175 78.5
Medical conditionsa
Yes 29 13.0
No 194 87.0
High risk proceduresb
Yes 143 64.1
No 80 35.9
Ward
Respiratory 99 44.4
Paediatric 47 21.1
Fever clinics 31 13.9
Emergency/ Intensive medicationc 46 20.6
Hospital
A 50 22.4
B 55 24.7
C 57 25.6
D 61 27.4
aInclude asthma, diabetes, immunosuppression and other
bInclude suctioning of airways, endotracheal intubation, sputum induction,
chest, physiotherapy bronchoscopy
c45 cases in emergency and 1 in intensive medication unitstudy (Table 2). If co-infections were excluded, bacteria
were isolated from 57% participants (128/223) at base-
line and 44% (98/223) at end of the study. Overall 196
(88%) participants had bacterial colonisation at start or
end of the study - 148 participants (66%) had only bacterial
colonisation while 48 (22%) participants had co-infection
with a virus (Fig. 1a). Among the total participants, 101
(45.5%) were positive for bacteria at both baseline and end
of the study, 68 (30.6%) were positive at baseline and nega-
tive at the end, 26 (11.7%) were negative at baseline and
positive at the end and 27 (12.2%) were negative at both
periods (Fig. 1b). Among all bacterial positive cases,
Streptococcus pneumoniae (isolated or co-infected with
Haemophilus influenza) was the most commonly isolated
organism at baseline (96%, 163/170) and end of the study
(72%, 91/127). Sixty-seven cases were positive for Strepto-
coccus pneumoniae at both baseline and end of the study –
18 from respiratory ward (18%, 18/99), 18 from paediatric
ward (38%, 18/47), 9 from fever clinics (29%, 9/31) and 22
from emergency ward (48%, 22/46).
There were 35 (15.7%) laboratory confirmed viral
infections found at baseline and 20 (9.0%) found at the
end of the study (Table 2). Rhinovirus/enterovirus was
the most common viral pathogen accounting for 24 (10.8%)Table 2 Laboratory results (n = 223)
Number
at the
baselinea
% Number
at the end
of studya
%
Bacteria isolated
Streptococcus pneumoniae 98 43.9 38 17
Haemophilus influenzae 7 3.1 36 16.1
Streptococcus pneumoniae and
Haemophilus influenzae
65 29.1 53 23.8
All bacteriac 170 76.2 127b 57
Only bacteria (no co-infection) 128 57.4 98 43.9
Virus isolated
Rhinovirus/Enterovirus 24 10.8 10 4.5
Influenza A (H3N2) 6 2.7 5 2.2
Rhinovirus/Enterovirus/Influenza
A (H3N2)
1 0.4 0 0
Otherd 4 1.8 5 2.2
All virusc 35 15.7 20 9.0
Only virus (no co-infection) 3 1.3 2 0.9
Co-infection 29 13.0 11 4.9
a101 cases were positive at both baseline and end of the study
bIncluding 26 new positive samples which were negative at baseline
cOne participant was not sampled at end of the study. Among 35 cases at
baseline - 14 were from respiratory ward, 6 from paediatric ward, 8 from fever
clinics and 7 from emergency ward. Among 20 cases at the end of the study -
7 were from respiratory ward, 8 from paediatric ward, 1 from fever clinics and
4 from emergency ward
dAt baseline other includes ADV [1], CoV229E [1], CoVC229E [1],
Metapneumovirus [1] and at the end of the study other includes ADV [2],
CoV229E [1], CoVC229E [1], Metapneumovirus [1]
Fig. 1 a Rates of bacterial, viral and co-infections; b Bacterial colonisation at baseline and at end of the study
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spectively. Other viruses detected included Adenovirus,
Coronavirus, H1N1 and H3N2 influenza virus and
human metapneumovirus. Rates of bacterial/viral co-
infections were 13% (29/223) at baseline and 4.9% (11/
223) at the end of the study.
Twelve participants (4.5%) developed clinical respiratory
illness (CRI) during the 4 week study period and all of
these 12 HCWs had positive bacteria isolation at baseline
(n = 11, including 4 co-infection with a virus) or end of
the study (n = 1). Among asymptomatic participants, 187
(87%) had bacterial colonisation or co-infection at baseline
or end of the study. Viruses were also isolated from 5
(2.4%) of asymptomatic cases (Table 3).
Rates of bacterial colonisation were compared among
symptomatic and non-symptomatic participants in the
Table 4. In all three outcomes, rates of bacterial colonisa-
tion were higher in symptomatic participants, compared
to non-symptomatic, although differences were not statis-
tically significant.Table 3 Rates of bacterial, viral and co-infection among symptomat
Symptomatic (CRI) Bacterial colonisation Viral infection
Yes (12) 8 (66.7%) 0
No (213) 140 (66.4%) 5 (2.4%)In univariate analysis, rates of bacterial colonisation were
higher (OR 0.31, 95% confidence interval 0.12 to 0.75) in
females (90.4%, 170/188) compared to males (74.3%, 26/35)
however this was not statistically significant (Table 5). No
other variable was associated with bacterial colonisation.
Discussion
We found a very high rate of bacterial colonisation in
HCWs, especially Streptococcus pneumonia, with fluctu-
ation in infections over a period of weeks. Almost 88%
of all HCWs had bacteria detected in the nasopharynx at
baseline, the end of the study period or both. This is a
much higher rate of colonisation compared to other studies
of adults. For example, other studies of adults show rates of
5–20% [27, 28]. We have previously shown only 0.3% of
elderly subjects carry pneumococcus in the nasopharynx.
The finding of such a high rate in this HCW population
may reflect greater exposure to respiratory infections in the
hospital setting and confirms the continual, ongoing risk to
HCWs in the hospital setting.ic and asymptomatic participants
Co-infection Negative swab Total
4 (33.3%) 0 12 (100%)
44 (20.9%) 22 (10.4%) 211 (100%)
Table 4 Comparing rates of bacterial colonisation in symptomatic
and non-symptomatic participants
CRI Bacterial colonisation Rate (%) OR P value
All bacteria positive at start or end of the study (including bacteria/viral
co-infections) (n = 223)
Yes 12/12 100 3.7 (0.19–72.55) 0.385
No 184/211 87.2 Ref
All bacteria positive at start or end of the study (excluding virus only
infection) (n = 218)
Yes 12/12 100 3.1 (0.16–59.69) 0.463
No 184/206 89.3 Ref
Only bacterial infection, excluding viral and co-infection infection cases
(n = 170)
Yes 8/8 100 2.72 (0.13–57.84) 0.521
No 140/162 86.4
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concern due to the risk of transmission to patients who are
ill and/or immunocompromised. Respiratory tract in-
fections generally present with symptoms such as fever,
tachypnea, shortness of breath and cough. However the
relationship of bacterial colonization to symptomatic
illness has not been studied extensively. We found a
very high and dynamic rate of bacterial colonisation in
hospital HCWs, with changes from baseline to the end
of the follow up period in the individuals with infection
as well as the types of infection.
Colonisation is important as this may progress to invasive
disease [1]. Bacterial colonisation may be an important
source of horizontal spread of infection within the commu-
nity [1]. Among 170 HCWs with positive bacterial result at
baseline, 68 (40%) became negative at the end of the study.
Natural clearance of bacteria in asymptomatic and symp-
tomatic subjects has not yet been studied. The rates of
bacterial colonisation in symptomatic HCWs were higher
than in asymptomatic HCWs, but this was not significant.
Bacterial colonisation in the majority of the HCWs resolved
without any treatment or development of symptoms. We
found 12 cases of CRI developed over 4 weeks, 11 of which
had bacterial colonisation at baseline. If bacterial shedding
occurs asymptomatically, then a large amount of un-
detected transmission may be occurring in hospitals.
This may be important for bacteria such as pneumococcus,
where the transition from carriage to invasive disease is
thought to occur soon after acquisition of infection.
Of interest, we identified 5 cases of asymptomatic viral
infection - four rhinovirus/enterovirus and one influenza
A(H3N2). Few studies have been conducted on the inci-
dence of asymptomatic viral infection, and of these, the
results are often inconsistent. One study examined the
rate of asymptomatic infection resulting from inocula-
tion and found that 1/3 of participants did not develop
any symptoms [23] whereas a more recent study foundthe rate of respiratory illness attributable to influenza
infection to be 27 respiratory illnesses per 100 persons
[29]. Our findings indicated a high rate of asymptomatic
infection at baseline, being cleared without the develop-
ment of symptoms. The clinical significance of such find-
ings is still unknown with limited information on viral
shedding and transmission in asymptomatic subjects. It is
well known that influenza virus is shed from the respira-
tory tract in the incubation period in asymptomatic sub-
jects, and asymptomatic infection has also been observed
with parainfluenza virus infection [22]. It has also been
found that viral shedding of influenza occurs on average
for 5 days after infection, indicating that some positive
tests could have been in HCWs recovering from influenza
[22]. Asymptomatic viral infections pose a significant risk
of nosocomial transmission to both patients and HCWs.
We found many co-infections in this study. Previous
studies have demonstrated that a viral infection may
facilitate bacterial colonisation or co-infection with S.
pneumoniae [30]. This may be a significant concern as
such co-infection has been associated with significantly
higher morbidity and mortality [31]. A growing body of
evidence suggests that the risk of bacterial respiratory
infections is increased by co-infection with viruses and
vice-versa, however bacterial respiratory tract infections
are generally not considered a major occupational hazard.
Despite documented outbreaks of Bordetella pertussis,
Chlamydia pneumoniae and Mycoplasma pneumoniae
[32–36], there are few prospective studies of bacterial
respiratory infections or colonization, nor consideration of
the clinical implications for HCWs. The risk of co-
infection has been reported in schools and daycare centres
with subsequent community transmission [3], but not in
HCWs. It has also been suggested that viral infection may
facilitate bacterial colonisation of the respiratory tract par-
ticularly with S. pneumoniae. Studies in mice have found
that influenza virus infection increases the transmission
and burden of pneumococcal disease [30]. Similar findings
have been reported in other studies demonstrating signifi-
cantly higher morbidity and mortality of cases with influ-
enza virus co-infection with S. pneumoniae [37]. This is
suggestive that the role and significance of viral infection in
the nasopharynx may be complex, highlighting the need for
further research into this topic.
Being a healthcare provider has been identified as a
major risk factor for respiratory infections [38, 39], how-
ever even within HCWs, the risk varies significantly. Hand
hygiene, use of personal protective equipment (PPE) and
working on intensive care units (ICUs) have been associ-
ated with risk of influenza [40]. Interestingly, factors such
as vaccination status, performing high-risk procedures,
working on respiratory and paediatric wards and smoking
were not found to be significant in predicting bacterial
colonisation in this study. Smoking, influenza vaccination
Table 5 Univariate and multivariate analysis (n = 223)
Variable Bacterial colonisation Rate OR (95% CI) AOR (95% CI) P value
CRI
Yes 12/12 100 3.72 (0.19 to 72.55) 3.64 (0.22 to 60.36) 0.367
No 184/211 87.2 Ref Ref
Gender
Male 26/35 74.3 0.31 (0.12 to 0.75) 0.33 (0.11 to 1.01) 0.052
Female 170/188 90.4 Ref Ref
Age 0.97 (0.93 to 1.02) 0.98 (0.93 to 1.03) 0.549
Profession
Doctor 89/104 85.6 0.66 (0.30 to 1.49) 0.92 (0.32 to 2.59) 0.869
Nurses 107/119 89.9 Ref Ref
Smoking status
Current/ex-smoker 8/11 72.7 0.34 (0.08 to 1.37) 0.54 (0.12 to 2.42) 0.418
Never 188/212 88.7 Ref Ref
Influenza vaccine
Yes 42/48 87.5 0.95 (0.36 to 2.52) 0.69 (0.26 to 1.86) 0.463
No 154/175 88
Medical conditionsa
Yes 25/29 86.2 0.84 (0.27 to 2.63) 0.77 (0.24 to 2.46) 0.664
No 171/194 88.1 Ref Ref
High risk proceduresb
Yes 124/143 86.7 0.72 (0.30 to 1.74) 0.72 (0.26 to 2.01) 0.528
No 72/80 88.9 Ref Ref
Mask use
Yes 172/196 87.8 0.90 (0.25 to 3.20) 0.83 (0.24 to 2.82) 0.765
No 24/27 88.9 Ref Ref
Ward
Respiratory 81/99 81.8 Ref Ref
Paediatric 44/47 93.6 3.26 (0.91 to 11.68) 2.72 (0.78 to 9.47) 0.117
Fever clinics 29/31 93.5 3.22 (0.70 to 14.75) 2.62 (0.56 to 12.24) 0.221
Emerg/ICUc 42/46 91.3 2.33 (0.74 to 7.38) 2.52 (0.77 to 8.24) 0.126
Bold shows significant result
aInclude asthma, diabetes, immunosuppression and other
bInclude suctioning of airways, endotracheal intubation, sputum induction, chest, physiotherapy bronchoscopy
c45 cases in emergency and 1 in intensive medication unit
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identified as risk factors for respiratory infection in various
groups [40, 41] however our findings suggest that such
risk factors may not be absolute and may vary in different
situations. The effect of vaccination also needs to be
studied. Some studies show that pneumococcal vaccin-
ation may reduce colonisation with vaccine-serotype
pneumococcal infection, though replacement by other
strains reduces the overall effect [1]. Previous studies
showed that medical masks and respirators reduce the
risk of bacterial respiratory infections [42], which fur-
ther supports the occurrence of nosocomial transmis-
sion of bacteria.The limitations of this study include that we did not
test for bacterial or viral infection at the time of reported
symptoms. This would confirm that an infection was the
cause of symptom development and also ensure that no
other infections were missed within the 4 weeks. Our sam-
ple size may have also been too small to detect differences
in colonisation between symptomatic and asymptomatic
subjects, or for analysis of risk factors such as smoking and
underlying disease as there were very few participants in
these categories. We were unable to recruit the initially
planned sample size so a larger scale study is warranted.
The selected follow up period of 4 weeks was the maximal
period of follow up possible within the available resources
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nally, these results may not be generalised due to varying
geographical distribution of pathogens and vaccine uptake
by country.
Conclusions
In summary, we have found very high rates (almost 88%)
of bacterial colonisation, viral infection and co-infections
in hospital HCWs, far higher than rates previously de-
scribed in adults. Most studies show that adults have rates
much lower than children, yet the rates we demonstrated
exceeded even colonisation rates in children, possibly
reflecting hospitals being a high exposure setting. Respira-
tory tract infections were also dynamic and changing over
time, with different HCWs infected at baseline and the
end of the study, with different pathogens. We were
unable to determine the relationship of symptoms to
colonisation because of a small sample size, but suggest
larger studies are warranted. Our results suggest there
is a continual ongoing risk of respiratory infection in
hospitals HCWs.
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